This is a Blanket Purchase Agreement (BPA) call issued by the Department of Veterans Affairs (VA) to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to provide reagents and consumables for in vitro diagnostic equipment. The contract is not set aside for any specific business type. The $343,039.29 ceiling value contract has an ultimate completion date of March 31, 2029 and was awarded on April 1, 2025. This BPA call is part of a larger $12.5 million BPA that the VA has with Abbott Molecular to provide Alinity diagnostics reagents, as well as a separate BPA to supply COVID-19 testing capacity worth over $6 million. Abbott Molecular has also received other IDIQ and BPA contracts from the VA, Army, and other federal agencies to provide a range of molecular diagnostics equipment, reagents, and testing services.
Generated 3/26/25, 10:01 AM